Dermapharm Holding SE (ETR:DMP)

Dermapharm Holding SE Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	118.57	158.72	151.02	161.41	120.3	114.96
Short-Term Investments	-	0.82	1.48	1.76	2.52	1.14
Cash & Short-Term Investments	118.57	159.54	152.5	163.18	122.82	116.09
Cash Growth	0.97%	4.62%	-6.54%	32.85%	5.80%	-45.40%
Accounts Receivable	123	95.41	96.72	72.52	55.52	48.88
Other Receivables	1.52	40.39	8.41	14.29	6.21	7.15
Receivables	124.52	135.8	105.13	86.81	61.72	56.03
Inventory	346.86	320.76	255.72	243.6	205.73	175.64
Prepaid Expenses	-	7.94	7	13.19	3.45	1.66
Other Current Assets	33.14	6.45	13.6	12.45	6.33	3.52
Total Current Assets	623.09	630.5	533.95	519.22	400.05	352.94
Property, Plant & Equipment	317.45	330.77	225.67	222.29	199.62	132.59
Long-Term Investments	23.55	25.34	36.57	105.62	60.7	62.8
Goodwill	578.49	578.52	271.32	264.73	266.27	202.25
Other Intangible Assets	519.86	441.61	212.12	217.13	235.24	241.05
Long-Term Deferred Charges	-	103.25	92.92	77.72	62.1	51.98
Other Long-Term Assets	60.61	0.68	0.28	0.27	0.41	1.27
Total Assets	2,123	2,161	1,413	1,407	1,224	1,045
Accounts Payable	92.15	86.64	56.1	52.1	50.37	35.36
Accrued Expenses	-	94.56	54.51	45.17	38.82	33.81
Short-Term Debt	-	0.01	0	-	-	5.96
Current Portion of Long-Term Debt	120.95	111.43	1.87	2.38	22.21	2.25
Current Portion of Leases	-	5	3.02	3.2	3.84	3.05
Current Income Taxes Payable	70.14	81.82	96.35	48.8	8.85	5.91
Current Unearned Revenue	-	1.43	0.56	0.62	1.06	0.68
Other Current Liabilities	91.68	13.61	5.38	3.35	7.72	15.4
Total Current Liabilities	374.92	394.49	217.79	155.61	132.87	102.42
Long-Term Debt	904.55	950.71	501.84	565.71	570.48	533.59
Long-Term Leases	-	13.25	9.72	9.01	10.28	9.76
Long-Term Unearned Revenue	-	11.69	9.2	9.46	9.72	10.07
Long-Term Deferred Tax Liabilities	110.94	112.39	50.52	36.06	29.95	27.04
Other Long-Term Liabilities	24.72	15.89	1.99	2.41	1.77	20.53
Total Liabilities	1,534	1,616	880.34	907.14	899.81	760.38
Common Stock	53.84	53.84	53.84	53.84	53.84	53.84
Retained Earnings	412.68	367.22	355.36	337.95	177.08	139.07
Comprehensive Income & Other	117.18	118.14	122.4	105.52	91.04	85.74
Total Common Equity	583.7	539.21	531.59	497.32	321.97	278.65
Minority Interest	5.33	5.84	0.9	2.52	2.62	5.84
Shareholders' Equity	589.04	545.05	532.49	499.83	324.58	284.49
Total Liabilities & Equity	2,123	2,161	1,413	1,407	1,224	1,045
Total Debt	1,025	1,080	516.45	580.3	606.8	554.61
Net Cash (Debt)	-906.93	-920.85	-363.95	-417.13	-483.98	-438.52
Net Cash Per Share	-16.81	-17.10	-6.76	-7.75	-8.99	-8.14
Filing Date Shares Outstanding	53.99	53.84	53.84	53.84	53.84	53.84
Total Common Shares Outstanding	53.99	53.84	53.84	53.84	53.84	53.84
Working Capital	248.17	236.01	316.16	363.61	267.18	250.52
Book Value Per Share	10.81	10.01	9.87	9.24	5.98	5.18
Tangible Book Value	-514.65	-480.92	48.15	15.46	-179.54	-164.65
Tangible Book Value Per Share	-9.53	-8.93	0.89	0.29	-3.33	-3.06
Land	-	252.54	171.75	163.41	147.52	102.54
Machinery	-	234.8	178.45	163.77	137.55	99

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.